Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  NY-ESO-1 peptide vaccine
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
Gene and Vaccine Therapy in Treating Patients with Advanced Malignancies
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 16 and over
Trial IDs: 12-000153, NCI-2012-01548, 1203-1157, 41.12.0-h, NCT01697527
NY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic Melanoma
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: LUD2012-004, NCI-2013-01366, NCT01810016
Start Over